Related Experiment Video
Updated: Aug 7, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
255
Meeting the Healthy People 2030 Added Sugars Target
Ellen W Stowe1, Latetia V Moore2, Heather C Hamner2
1Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, Tennessee.
American Journal of Preventive Medicine
|March 12, 2023
Summary
Meeting Healthy People 2030 goals for added sugars is achievable. Modest daily reductions of 14–57 calories in added sugars intake can help Americans meet dietary targets.
Area of Science:
- Nutrition Science
- Public Health
- Dietary Guidelines
Background:
- Many Americans consume excessive dietary added sugars, exceeding recommended intake levels.
- The Healthy People 2030 initiative aims to reduce added sugar consumption to 11.5% of daily calories for individuals aged two and older.
Purpose of the Study:
- To determine the necessary reductions in added sugars intake across different population groups to achieve the Healthy People 2030 target.
- To evaluate four distinct public health strategies for reducing population-level added sugar consumption.
Main Methods:
- Utilized data from the 2015-2018 National Health and Nutrition Examination Survey (n=15,038).
- Employed the National Cancer Institute method to estimate usual added sugar intake as a percentage of daily calories.
- Investigated four reduction approaches targeting the general population, those exceeding recommendations, high consumers, and specific intake thresholds.
Main Results:
- Achieving the Healthy People 2030 target requires average daily reductions of 13.7 to 56.6 calories from added sugars, varying by approach.
- Reductions needed were 13.7 calories/day (general population), 22.0 calories/day (exceeding guidelines), and 56.6 calories/day (high consumers).
- Observed variations in added sugars intake and reduction impact across different sociodemographic groups, including race/ethnicity, age, and income.
Conclusions:
- The Healthy People 2030 target for added sugars is attainable through feasible dietary modifications.
- Modest reductions in daily added sugars intake, ranging from 14 to 57 calories, are sufficient depending on the public health strategy employed.
Related Concept Videos
01:15Carbohydrates: Dietary Sources and Requirements
593
Carbohydrates are predominantly obtained from plant sources. With the exception of lactose found in milk and insignificant glycogen amounts in meat, most consumed carbohydrates have plant origins. Monosaccharides and disaccharides, or sugars, can be sourced from fruits, honey, milk, sugar cane, and sugar beets. Grains and vegetables are rich in the polysaccharide starch. Two types of polysaccharides provide fiber: cellulose, which is abundant in many vegetables, forms undigestible roughage or...
593
01:10Sugars as Energy Storage Molecules
8.7K
Sugar (a simple carbohydrate) metabolism (chemical reactions) is a classic example of the many cellular processes that use and produce energy. Living things consume sugar as a major energy source because sugar molecules have considerable energy stored within their bonds. Consumed carbohydrates have their origins in photosynthesizing organisms like plants. During photosynthesis, plants use the energy of sunlight to convert carbon dioxide gas into sugar molecules, like glucose. Because this...
8.7K
01:17Oral Hypoglycemic Agents: Sulfonylureas
268
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
268
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
250
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
250
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
225
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
225
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K